www.hivandhepatitis.com

Back HCV Treatment

DDW 2008: Antiviral Activity, Pharmacodynamics, and Quality of Life in Genotype 1 Hepatitis C Patients Treated with Albinterferon (Albuferon)

Details
Category: Experimental HCV Drugs
Published on Friday, 23 May 2008 13:46
Written by Liz Highleyman
  • Print

Albinterferon alfa-2b (albumin interferon; brand name Albuferon) is created by fusing interferon alfa with the human blood protein albumin, which enables it to last longer in the body. Albinterferon may be administered once every 2 to 4 weeks, compared with 3 times weekly for conventional interferon alfa and once-weekly for pegylated interferon alfa (Pegasys or PegIntron).

Read more:

Subcategories

Copyright © 2025 www.hivandhepatitis.com. All Rights Reserved. Designed by JoomlArt.com. Joomla! is Free Software released under the GNU General Public License.

Bread and Roses Web DesignWeb Design and Development by Bread and Roses Web Design